Line 2,988: |
Line 2,988: |
| | | |
| ==WHO Central Nervous System Tumours (5th ed.) Content== | | ==WHO Central Nervous System Tumours (5th ed.) Content== |
| + | |
| + | } |
| {| class="wikitable" | | {| class="wikitable" |
| |- | | |- |
Line 2,998: |
Line 3,000: |
| !'''Notes''' | | !'''Notes''' |
| |- | | |- |
− | | Astrocytoma, IDH-mutant||Disease|| | + | |Astrocytoma, IDH-mutant||Disease|| |
| | | | | |
| | | | | |
Line 3,006: |
Line 3,008: |
| | | | | |
| |- | | |- |
− | | Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease|| | + | |Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease|| |
| | | | | |
| | | | | |
Line 3,014: |
Line 3,016: |
| | | | | |
| |- | | |- |
− | | Glioblastoma, IDH-wildtype||Disease|| | + | |Glioblastoma, IDH-wildtype||Disease|| |
| | | | | |
| | | | | |
Line 3,022: |
Line 3,024: |
| | | | | |
| |- | | |- |
− | | Diffuse astrocytoma, MYB- or MYBL1-altered||Disease|| | + | |Diffuse astrocytoma, MYB- or MYBL1-altered||Disease|| |
| | | | | |
| | | | | |
Line 3,030: |
Line 3,032: |
| | | | | |
| |- | | |- |
− | | Angiocentric glioma||Disease|| | + | |Angiocentric glioma||Disease|| |
| | | | | |
| | | | | |
Line 3,038: |
Line 3,040: |
| | | | | |
| |- | | |- |
− | | Polymorphous low-grade neuroepithelial tumour of the young||Disease|| | + | |Polymorphous low-grade neuroepithelial tumour of the young||Disease|| |
| | | | | |
| | | | | |
Line 3,046: |
Line 3,048: |
| | | | | |
| |- | | |- |
− | | Diffuse low-grade glioma, MAPK pathway-altered ||Disease|| | + | |Diffuse low-grade glioma, MAPK pathway-altered||Disease|| |
| | | | | |
| | | | | |
Line 3,054: |
Line 3,056: |
| | | | | |
| |- | | |- |
− | | Diffuse midline glioma, H3 K27-altered||Disease|| | + | |Diffuse midline glioma, H3 K27-altered||Disease|| |
| | | | | |
| | | | | |
Line 3,062: |
Line 3,064: |
| | | | | |
| |- | | |- |
− | | Diffuse hemispheric glioma, H3 G34-mutant||Disease|| | + | |Diffuse hemispheric glioma, H3 G34-mutant||Disease|| |
| | | | | |
| | | | | |
Line 3,070: |
Line 3,072: |
| | | | | |
| |- | | |- |
− | | Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease|| | + | |Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease|| |
| | | | | |
| | | | | |
Line 3,078: |
Line 3,080: |
| | | | | |
| |- | | |- |
− | | Infant-type hemispheric glioma||Disease|| | + | |Infant-type hemispheric glioma||Disease|| |
| | | | | |
| | | | | |
Line 3,086: |
Line 3,088: |
| | | | | |
| |- | | |- |
− | | Pilocytic astrocytoma ||Disease|| | + | |Pilocytic astrocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,094: |
Line 3,096: |
| | | | | |
| |- | | |- |
− | | High-grade astrocytoma with piloid features||Disease|| | + | |High-grade astrocytoma with piloid features||Disease|| |
| | | | | |
| | | | | |
Line 3,102: |
Line 3,104: |
| | | | | |
| |- | | |- |
− | | Pleomorphic xanthoastrocytoma||Disease|| | + | |Pleomorphic xanthoastrocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,110: |
Line 3,112: |
| | | | | |
| |- | | |- |
− | | Subependymal giant cell astrocytoma||Disease|| | + | |Subependymal giant cell astrocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,118: |
Line 3,120: |
| | | | | |
| |- | | |- |
− | | Chordoid glioma||Disease|| | + | |Chordoid glioma||Disease|| |
| | | | | |
| | | | | |
Line 3,126: |
Line 3,128: |
| | | | | |
| |- | | |- |
− | | Astroblastoma, MN1-altered||Disease|| | + | |Astroblastoma, MN1-altered||Disease|| |
| | | | | |
| | | | | |
Line 3,134: |
Line 3,136: |
| | | | | |
| |- | | |- |
− | | Ganglioglioma||Disease|| | + | |Ganglioglioma||Disease|| |
| | | | | |
| | | | | |
Line 3,142: |
Line 3,144: |
| | | | | |
| |- | | |- |
− | | Gangliocytoma||Disease|| | + | |Gangliocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,150: |
Line 3,152: |
| | | | | |
| |- | | |- |
− | | Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease|| | + | |Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,158: |
Line 3,160: |
| | | | | |
| |- | | |- |
− | | Dysembryoplastic neuroepithelial tumour||Disease|| | + | |Dysembryoplastic neuroepithelial tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,166: |
Line 3,168: |
| | | | | |
| |- | | |- |
− | | Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease|| | + | |Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease|| |
| | | | | |
| | | | | |
Line 3,174: |
Line 3,176: |
| | | | | |
| |- | | |- |
− | | Papillary glioneuronal tumour||Disease|| | + | |Papillary glioneuronal tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,182: |
Line 3,184: |
| | | | | |
| |- | | |- |
− | | Rosette-forming glioneuronal tumour||Disease|| | + | |Rosette-forming glioneuronal tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,190: |
Line 3,192: |
| | | | | |
| |- | | |- |
− | | Myxoid glioneuronal tumour||Disease|| | + | |Myxoid glioneuronal tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,198: |
Line 3,200: |
| | | | | |
| |- | | |- |
− | | Diffuse leptomeningeal glioneuronal tumour||Disease|| | + | |Diffuse leptomeningeal glioneuronal tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,206: |
Line 3,208: |
| | | | | |
| |- | | |- |
− | | Multinodular and vacuolating neuronal tumour||Disease|| | + | |Multinodular and vacuolating neuronal tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,214: |
Line 3,216: |
| | | | | |
| |- | | |- |
− | | Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease|| | + | |Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease|| |
| | | | | |
| | | | | |
Line 3,222: |
Line 3,224: |
| | | | | |
| |- | | |- |
− | | Central neurocytoma||Disease|| | + | |Central neurocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,230: |
Line 3,232: |
| | | | | |
| |- | | |- |
− | | Extraventricular neurocytoma||Disease|| | + | |Extraventricular neurocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,238: |
Line 3,240: |
| | | | | |
| |- | | |- |
− | | Cerebellar liponeurocytoma||Disease|| | + | |Cerebellar liponeurocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,246: |
Line 3,248: |
| | | | | |
| |- | | |- |
− | | Supratentorial ependymoma||Disease|| | + | |Supratentorial ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 3,254: |
Line 3,256: |
| | | | | |
| |- | | |- |
− | | Supratentorial ependymoma, ZFTA fusion-positive ||Disease|| | + | |Supratentorial ependymoma, ZFTA fusion-positive||Disease|| |
| | | | | |
| | | | | |
Line 3,262: |
Line 3,264: |
| | | | | |
| |- | | |- |
− | | Supratentorial ependymoma, YAP1 fusion-positive||Disease|| | + | |Supratentorial ependymoma, YAP1 fusion-positive||Disease|| |
| | | | | |
| | | | | |
Line 3,270: |
Line 3,272: |
| | | | | |
| |- | | |- |
− | | Posterior fossa ependymoma||Disease|| | + | |Posterior fossa ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 3,278: |
Line 3,280: |
| | | | | |
| |- | | |- |
− | | Posterior fossa group A (PFA) ependymoma||Disease|| | + | |Posterior fossa group A (PFA) ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 3,286: |
Line 3,288: |
| | | | | |
| |- | | |- |
− | | Posterior fossa group B (PFB) ependymoma||Disease|| | + | |Posterior fossa group B (PFB) ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 3,294: |
Line 3,296: |
| | | | | |
| |- | | |- |
− | | Spinal ependymoma||Disease|| | + | |Spinal ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 3,302: |
Line 3,304: |
| | | | | |
| |- | | |- |
− | | Spinal ependymoma, MYCN-amplified||Disease|| | + | |Spinal ependymoma, MYCN-amplified||Disease|| |
| | | | | |
| | | | | |
Line 3,310: |
Line 3,312: |
| | | | | |
| |- | | |- |
− | | Myxopapillary ependymoma||Disease|| | + | |Myxopapillary ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 3,318: |
Line 3,320: |
| | | | | |
| |- | | |- |
− | | Subependymoma||Disease|| | + | |Subependymoma||Disease|| |
| | | | | |
| | | | | |
Line 3,326: |
Line 3,328: |
| | | | | |
| |- | | |- |
− | | Choroid plexus papilloma||Disease|| | + | |Choroid plexus papilloma||Disease|| |
| | | | | |
| | | | | |
Line 3,334: |
Line 3,336: |
| | | | | |
| |- | | |- |
− | | Atypical choroid plexus papilloma||Disease|| | + | |Atypical choroid plexus papilloma||Disease|| |
| | | | | |
| | | | | |
Line 3,342: |
Line 3,344: |
| | | | | |
| |- | | |- |
− | | Choroid plexus carcinoma||Disease|| | + | |Choroid plexus carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,350: |
Line 3,352: |
| | | | | |
| |- | | |- |
− | | Medulloblastoma, WNT-activated||Disease|| | + | |Medulloblastoma, WNT-activated||Disease|| |
| | | | | |
| | | | | |
Line 3,358: |
Line 3,360: |
| | | | | |
| |- | | |- |
− | | Medulloblastoma, SHH-activated and TP53-wildtype||Disease|| | + | |Medulloblastoma, SHH-activated and TP53-wildtype||Disease|| |
| | | | | |
| | | | | |
Line 3,366: |
Line 3,368: |
| | | | | |
| |- | | |- |
− | | Medulloblastoma, SHH-activated and TP53-mutant||Disease|| | + | |Medulloblastoma, SHH-activated and TP53-mutant||Disease|| |
| | | | | |
| | | | | |
Line 3,374: |
Line 3,376: |
| | | | | |
| |- | | |- |
− | | Medulloblastoma, non-WNT/non-SHH||Disease|| | + | |Medulloblastoma, non-WNT/non-SHH||Disease|| |
| | | | | |
| | | | | |
Line 3,382: |
Line 3,384: |
| | | | | |
| |- | | |- |
− | | Medulloblastoma, histologically defined||Disease|| | + | |Medulloblastoma, histologically defined||Disease|| |
| | | | | |
| | | | | |
Line 3,390: |
Line 3,392: |
| | | | | |
| |- | | |- |
− | | Atypical teratoid/rhabdoid tumour||Disease|| | + | |Atypical teratoid/rhabdoid tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,398: |
Line 3,400: |
| | | | | |
| |- | | |- |
− | | Cribriform neuroepithelial tumour||Disease|| | + | |Cribriform neuroepithelial tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,406: |
Line 3,408: |
| | | | | |
| |- | | |- |
− | | Embryonal tumour with multilayered rosettes||Disease|| | + | |Embryonal tumour with multilayered rosettes||Disease|| |
| | | | | |
| | | | | |
Line 3,414: |
Line 3,416: |
| | | | | |
| |- | | |- |
− | | CNS neuroblastoma, FOXR2-activated||Disease|| | + | |CNS neuroblastoma, FOXR2-activated||Disease|| |
| | | | | |
| | | | | |
Line 3,422: |
Line 3,424: |
| | | | | |
| |- | | |- |
− | | CNS tumour with BCOR internal tandem duplication||Disease|| | + | |CNS tumour with BCOR internal tandem duplication||Disease|| |
| | | | | |
| | | | | |
Line 3,430: |
Line 3,432: |
| | | | | |
| |- | | |- |
− | | CNS embryonal tumour NEC/NOS||Disease|| | + | |CNS embryonal tumour NEC/NOS||Disease|| |
| | | | | |
| | | | | |
Line 3,438: |
Line 3,440: |
| | | | | |
| |- | | |- |
− | | Pineocytoma||Disease|| | + | |Pineocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,446: |
Line 3,448: |
| | | | | |
| |- | | |- |
− | | Pineal parenchymal tumour of intermediate differentiation||Disease|| | + | |Pineal parenchymal tumour of intermediate differentiation||Disease|| |
| | | | | |
| | | | | |
Line 3,454: |
Line 3,456: |
| | | | | |
| |- | | |- |
− | | Pineoblastoma||Disease|| | + | |Pineoblastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,462: |
Line 3,464: |
| | | | | |
| |- | | |- |
− | | Papillary tumour of the pineal region||Disease|| | + | |Papillary tumour of the pineal region||Disease|| |
| | | | | |
| | | | | |
Line 3,470: |
Line 3,472: |
| | | | | |
| |- | | |- |
− | | Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease|| | + | |Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease|| |
| | | | | |
| | | | | |
Line 3,478: |
Line 3,480: |
| | | | | |
| |- | | |- |
− | | Schwannoma||Disease|| | + | |Schwannoma||Disease|| |
| | | | | |
| | | | | |
Line 3,486: |
Line 3,488: |
| | | | | |
| |- | | |- |
− | | Neurofibroma||Disease|| | + | |Neurofibroma||Disease|| |
| | | | | |
| | | | | |
Line 3,494: |
Line 3,496: |
| | | | | |
| |- | | |- |
− | | Perineurioma||Disease|| | + | |Perineurioma||Disease|| |
| | | | | |
| | | | | |
Line 3,502: |
Line 3,504: |
| | | | | |
| |- | | |- |
− | | Hybrid nerve sheath tumours||Disease|| | + | |Hybrid nerve sheath tumours||Disease|| |
| | | | | |
| | | | | |
Line 3,510: |
Line 3,512: |
| | | | | |
| |- | | |- |
− | | Malignant melanotic nerve sheath tumour||Disease|| | + | |Malignant melanotic nerve sheath tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,518: |
Line 3,520: |
| | | | | |
| |- | | |- |
− | | Malignant peripheral nerve sheath tumour||Disease|| | + | |Malignant peripheral nerve sheath tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,526: |
Line 3,528: |
| | | | | |
| |- | | |- |
− | | Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease|| | + | |Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease|| |
| | | | | |
| | | | | |
Line 3,534: |
Line 3,536: |
| | | | | |
| |- | | |- |
− | | Meningioma||Disease|| | + | |Meningioma||Disease|| |
| | | | | |
| | | | | |
Line 3,542: |
Line 3,544: |
| | | | | |
| |- | | |- |
− | | Solitary fibrous tumour||Disease|| | + | |Solitary fibrous tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,550: |
Line 3,552: |
| | | | | |
| |- | | |- |
− | | Haemangiomas and vascular malformations||Disease|| | + | |Haemangiomas and vascular malformations||Disease|| |
| | | | | |
| | | | | |
Line 3,558: |
Line 3,560: |
| | | | | |
| |- | | |- |
− | | Haemangioblastoma||Disease|| | + | |Haemangioblastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,566: |
Line 3,568: |
| | | | | |
| |- | | |- |
− | | Rhabdomyosarcoma||Disease|| | + | |Rhabdomyosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,574: |
Line 3,576: |
| | | | | |
| |- | | |- |
− | | Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease|| | + | |Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease|| |
| | | | | |
| | | | | |
Line 3,582: |
Line 3,584: |
| | | | | |
| |- | | |- |
− | | CIC-rearranged sarcoma||Disease|| | + | |CIC-rearranged sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,590: |
Line 3,592: |
| | | | | |
| |- | | |- |
− | | Primary intracranial sarcoma, DICER1-mutant||Disease|| | + | |Primary intracranial sarcoma, DICER1-mutant||Disease|| |
| | | | | |
| | | | | |
Line 3,598: |
Line 3,600: |
| | | | | |
| |- | | |- |
− | | Ewing sarcoma||Disease|| | + | |Ewing sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,606: |
Line 3,608: |
| | | | | |
| |- | | |- |
− | | Mesenchymal chondrosarcoma||Disease|| | + | |Mesenchymal chondrosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,614: |
Line 3,616: |
| | | | | |
| |- | | |- |
− | | Chondrosarcoma||Disease|| | + | |Chondrosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,622: |
Line 3,624: |
| | | | | |
| |- | | |- |
− | | Chordoma||Disease|| | + | |Chordoma||Disease|| |
| | | | | |
| | | | | |
Line 3,630: |
Line 3,632: |
| | | | | |
| |- | | |- |
− | | Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease|| | + | |Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease|| |
| | | | | |
| | | | | |
Line 3,638: |
Line 3,640: |
| | | | | |
| |- | | |- |
− | | Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease|| | + | |Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease|| |
| | | | | |
| | | | | |
Line 3,646: |
Line 3,648: |
| | | | | |
| |- | | |- |
− | | Primary diffuse large B-cell lymphoma of the CNS||Disease|| | + | |Primary diffuse large B-cell lymphoma of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 3,654: |
Line 3,656: |
| | | | | |
| |- | | |- |
− | | Immunodeficiency-associated CNS lymphomas||Disease|| | + | |Immunodeficiency-associated CNS lymphomas||Disease|| |
| | | | | |
| | | | | |
Line 3,662: |
Line 3,664: |
| | | | | |
| |- | | |- |
− | | Lymphomatoid granulomatosis||Disease|| | + | |Lymphomatoid granulomatosis||Disease|| |
| | | | | |
| | | | | |
Line 3,670: |
Line 3,672: |
| | | | | |
| |- | | |- |
− | | Intravascular large B-cell lymphoma||Disease|| | + | |Intravascular large B-cell lymphoma||Disease|| |
| | | | | |
| | | | | |
Line 3,678: |
Line 3,680: |
| | | | | |
| |- | | |- |
− | | MALT lymphoma of the dura||Disease|| | + | |MALT lymphoma of the dura||Disease|| |
| | | | | |
| | | | | |
Line 3,686: |
Line 3,688: |
| | | | | |
| |- | | |- |
− | | Other low-grade B-cell lymphomas of the CNS||Disease|| | + | |Other low-grade B-cell lymphomas of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 3,694: |
Line 3,696: |
| | | | | |
| |- | | |- |
− | | Anaplastic large cell lymphoma (ALK+/ALK−)||Disease|| | + | |Anaplastic large cell lymphoma (ALK+/ALK−)||Disease|| |
| | | | | |
| | | | | |
Line 3,702: |
Line 3,704: |
| | | | | |
| |- | | |- |
− | | T-cell and NK/T-cell lymphomas||Disease|| | + | |T-cell and NK/T-cell lymphomas||Disease|| |
| | | | | |
| | | | | |
Line 3,710: |
Line 3,712: |
| | | | | |
| |- | | |- |
− | | Erdheim-Chester disease||Disease|| | + | |Erdheim-Chester disease||Disease|| |
| | | | | |
| | | | | |
Line 3,718: |
Line 3,720: |
| | | | | |
| |- | | |- |
− | | Rosai-Dorfman disease||Disease|| | + | |Rosai-Dorfman disease||Disease|| |
| | | | | |
| | | | | |
Line 3,726: |
Line 3,728: |
| | | | | |
| |- | | |- |
− | | Juvenile xanthogranuloma||Disease|| | + | |Juvenile xanthogranuloma||Disease|| |
| | | | | |
| | | | | |
Line 3,734: |
Line 3,736: |
| | | | | |
| |- | | |- |
− | | Langerhans cell histiocytosis||Disease|| | + | |Langerhans cell histiocytosis||Disease|| |
| | | | | |
| | | | | |
Line 3,742: |
Line 3,744: |
| | | | | |
| |- | | |- |
− | | Histiocytic sarcoma||Disease|| | + | |Histiocytic sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,750: |
Line 3,752: |
| | | | | |
| |- | | |- |
− | | Germ cell tumours of the CNS||Disease|| | + | |Germ cell tumours of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 3,758: |
Line 3,760: |
| | | | | |
| |- | | |- |
− | | Adamantinomatous craniopharyngioma||Disease|| | + | |Adamantinomatous craniopharyngioma||Disease|| |
| | | | | |
| | | | | |
Line 3,766: |
Line 3,768: |
| | | | | |
| |- | | |- |
− | | Papillary craniopharyngioma||Disease|| | + | |Papillary craniopharyngioma||Disease|| |
| | | | | |
| | | | | |
Line 3,774: |
Line 3,776: |
| | | | | |
| |- | | |- |
− | | Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease|| | + | |Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,782: |
Line 3,784: |
| | | | | |
| |- | | |- |
− | | Pituitary adenoma / pituitary neuroendocrine tumour||Disease|| | + | |Pituitary adenoma / pituitary neuroendocrine tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,790: |
Line 3,792: |
| | | | | |
| |- | | |- |
− | | Pituitary blastoma||Disease|| | + | |Pituitary blastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,798: |
Line 3,800: |
| | | | | |
| |- | | |- |
− | | Metastases to the brain and spinal cord parenchyma||Disease|| | + | |Metastases to the brain and spinal cord parenchyma||Disease|| |
| | | | | |
| | | | | |
Line 3,806: |
Line 3,808: |
| | | | | |
| |- | | |- |
− | | Metastases to the meninges||Disease|| | + | |Metastases to the meninges||Disease|| |
| | | | | |
| | | | | |
Line 3,814: |
Line 3,816: |
| | | | | |
| |- | | |- |
− | | Neurofibromatosis type 1||Disease|| | + | |Neurofibromatosis type 1||Disease|| |
| | | | | |
| | | | | |
Line 3,822: |
Line 3,824: |
| | | | | |
| |- | | |- |
− | | Neurofibromatosis type 2||Disease|| | + | |Neurofibromatosis type 2||Disease|| |
| | | | | |
| | | | | |
Line 3,830: |
Line 3,832: |
| | | | | |
| |- | | |- |
− | | Schwannomatosis||Disease|| | + | |Schwannomatosis||Disease|| |
| | | | | |
| | | | | |
Line 3,838: |
Line 3,840: |
| | | | | |
| |- | | |- |
− | | Von Hippel-Lindau syndrome||Disease|| | + | |Von Hippel-Lindau syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,846: |
Line 3,848: |
| | | | | |
| |- | | |- |
− | | Tuberous sclerosis||Disease|| | + | |Tuberous sclerosis||Disease|| |
| | | | | |
| | | | | |
Line 3,854: |
Line 3,856: |
| | | | | |
| |- | | |- |
− | | Li-Fraumeni syndrome||Disease|| | + | |Li-Fraumeni syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,862: |
Line 3,864: |
| | | | | |
| |- | | |- |
− | | Cowden syndrome||Disease|| | + | |Cowden syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,870: |
Line 3,872: |
| | | | | |
| |- | | |- |
− | | Constitutional mismatch repair deficiency syndrome||Disease|| | + | |Constitutional mismatch repair deficiency syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,878: |
Line 3,880: |
| | | | | |
| |- | | |- |
− | | Familial adenomatous polyposis 1||Disease|| | + | |Familial adenomatous polyposis 1||Disease|| |
| | | | | |
| | | | | |
Line 3,886: |
Line 3,888: |
| | | | | |
| |- | | |- |
− | | Naevoid basal cell carcinoma syndrome||Disease|| | + | |Naevoid basal cell carcinoma syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,894: |
Line 3,896: |
| | | | | |
| |- | | |- |
− | | Rhabdoid tumour predisposition syndrome||Disease|| | + | |Rhabdoid tumour predisposition syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,902: |
Line 3,904: |
| | | | | |
| |- | | |- |
− | | Carney complex||Disease|| | + | |Carney complex||Disease|| |
| | | | | |
| | | | | |
Line 3,910: |
Line 3,912: |
| | | | | |
| |- | | |- |
− | | DICER1 syndrome||Disease|| | + | |DICER1 syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,918: |
Line 3,920: |
| | | | | |
| |- | | |- |
− | | Familial paraganglioma syndromes||Disease|| | + | |Familial paraganglioma syndromes||Disease|| |
| | | | | |
| | | | | |
Line 3,926: |
Line 3,928: |
| | | | | |
| |- | | |- |
− | | Melanoma-astrocytoma syndrome||Disease|| | + | |Melanoma-astrocytoma syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,934: |
Line 3,936: |
| | | | | |
| |- | | |- |
− | | Familial retinoblastoma||Disease|| | + | |Familial retinoblastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,942: |
Line 3,944: |
| | | | | |
| |- | | |- |
− | | BAP1 tumour predisposition syndrome||Disease|| | + | |BAP1 tumour predisposition syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,950: |
Line 3,952: |
| | | | | |
| |- | | |- |
− | | Fanconi anaemia||Disease|| | + | |Fanconi anaemia||Disease|| |
| | | | | |
| | | | | |
Line 3,958: |
Line 3,960: |
| | | | | |
| |- | | |- |
− | | ELP1-medulloblastoma syndrome||Disease|| | + | |ELP1-medulloblastoma syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,966: |
Line 3,968: |
| | | | | |
| |- | | |- |
− | } | + | |} |